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Introduction
The main goal for surgery of the dilated ascending aorta is 
to prevent aortic dissection (AD) and rupture (1, 2). AD consists 
of an aortic wall tear in a tangential fashion and represents the 
ultimate rupture due to aortic wall weakness. Pathophysiologi-
cally, AD and aortic rupture are interrelated and are manifested 
by the anatomical site of the aortic tear (2). Despite the sudden 
occurrence of the aortic tear, the ascending aorta may have 
undergone a chronic remodeling phase of tissue weakening, in-
cluding aortic wall hypoxia, hypertension, and chronic inflamma-
tion. Although a borderline of a 5.5 cm diameter of the ascending 
aorta is regarded as the threshold in enhancing the risk for AD 
(2), there is increasing evidence that aortas with an even smaller 
diameter may lead to AD (3). The decision for the extension of re-
section of the aorta during surgery is challenging, as one would 
aim at preventing AD after surgery.
The perioperative evaluation of the resected aortic wall dur-
ing surgery for ascending aorta may reveal susceptibility for AD 
necessitating further extension of surgery. Most AD occurs in 
the outer third of the media close to the adventitia (4). This site is 
characterized by vasa vasorum that participates in the nutrition 
of the aortic wall (4). The significance of endothelial activation 
of vasa vasorum in aortic pathogenesis is under discussion (5). 
Arterial neovascularization may be regulated by chronic inflam-
mation, suggesting that hypoxia alone is not leading to tissue re-
modeling (6). Recent experimental studies suggest that the regu-
lation of angiogenesis is dependent on endothelial activation (7).
We studied the vascular reactivity of the aortic wall by char-
acterizing the angiogenic histology of the ascending aorta as 
expressed by CD31. We hypothesized that chronic inflammatory 
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remodeling of the ascending aorta is associated with dilatation 
of the aortic wall, and neovascularization of the ascending aor-
tic media may determine the fate of the dilated aortic wall. Us-
ing an extensive immunohistochemical analysis and detection of 
CD31-positive endothelial cells of the medial layer, we evaluated 
whether neovascularization is associated with AD.
Methods
Study protocol and surgery
After an institutional review board approval, the need for in-
formed consent was waived. The ascending aortic wall resection 
of 35 consecutive patients undergoing surgery for ascending aor-
ta was obtained and processed for histology. An ascending aor-
tic aneurysm was preoperatively confirmed and evaluated with 
computed tomography (CT). According to our institutional policy, 
aortic aneurysm included an aortic diameter wider than 5.5 cm or 
aortic growth greater than 1 cm in a year. This definition was ad-
justed to the presence of Marfan syndrome, gender, patient size, 
and symptoms, including AD according to the Yale Center criteria 
(2). Surgery was performed between December 2009 and August 
2014, and cases of ascending aortas including AD processed for 
histology were enrolled. Three patients with Marfan syndrome 
were excluded. There were 14 patients with acute AD including 
onset of symptoms that lasted less than 7 days. 
The decision on the extension of resection and surgical tech-
nique was at the discretion of the operating surgeon. When an 
aortic aneurysm including the sinotubular junction (STJ) was 
estimated as the reason for aortic regurgitation, STJ was tai-
lored for a suitable graft in a supracoronary fashion. Whenever 
dilatation included the aorta root, a radical resection of the di-
lated ascending aorta together with the root and the aortic valve 
was performed. The graft size was estimated by the principal 
surgeon. The entry tears were located in the middle portion of 
the ascending aorta according to pre-operative CT and intra-
operative assessment. Since the surgical procedure was per-
formed upon surgical decision, the sample was procured from 
the middle of the resected diseased area of the ascending aorta 
at the vicinity of STJ.
Histology and immunohistochemistry
Two to five blocks of resected ascending aorta were embed-
ded in paraffin, cut to 4-mm-thick segments and stained with 
hematoxylin and eosin, Verhoeff-van Gieson, Elastase-van Gie-
son, and Periodic Acid-Schiff. A representative 1-cm-long piece 
of ascending aortic wall corresponding to all different staining 
was evaluated systematically for all resected samples procured 
during surgery. 
Aortic wall histology and immunohistochemistry were per-
formed using Ventana Lifesciences Benchmark XT Staining 
module for leukocytes, T- and B-lymphocytes, plasma cells, 
macrophages, smooth muscle cells, cell proliferation, elastase, 
and van Gieson staining. The samples were further investigated 
for presence and locality of neovascularity within the aortic 
wall; capillaries with endothelial cells were evaluated using a 
polyclonal rabbit antibody for CD31 (dilution 1:2500) (DakoCyma-
tion). Ventana Lifesciences Antibody Dilution Buffer was utilized 
for dilution media. The heights of different layers (adventitia, me-
dia, and intima) were calculated for each sample. Inflammatory 
cells, the intensity of inflammation, cell proliferation, medial de-
generation, intima cellularity, and thickness were estimated as 
previously described and expressed as point score units (PSU) 
in the three aortic wall layers accordingly (8). Briefly, inflamma-
tion was graded as none, mild, moderate, or severe (0, 1, 2, or 3). 
Medial degeneration was graded as patchy, moderate, or severe 
again on a scale of 0–3. Intima cellularity and thickness were 
estimated according to an arbitrary scale from 0–3, where 0 indi-
cated normal intima with a single endothelial cell layer; 1, intima 
cellularity and thickness less than 25% as compared with the 
media; 2, intima cellularity and thickness more than 25% but less 
than 50% as compared with the media; 3, intensive intima cellu-
larity and thickness more than 50% as compared with the media.
Quantification of medial neovascularization
Platelet endothelial cell adhesion molecule 1 (PECAM-1), 
also known as CD31 (cluster of differentiation 31), is expressed 
a
b
Figure 1. Representative immunohistochemistry (x20) for CD31 of the 
ascending aorta. Note the CD31 positivity (white arrow) in the outer 
third medial layer of the ascending aorta suggesting susceptibility for 
aortic dissection in (a) The onset of dissection (white brackets) in b at 
the site of CD31 positivity (white arrow). Inlets (x40) at the bottom left 
corner show the site of interests in detail.
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in high amounts in endothelial cell junctions (9). As CD31 may 
be expressed by leukocytes and platelets (10), angiogenesis 
was defined by accounting CD31-positivity, including only cap-
illary-like morphology with a continuous uninterrupted endothe-
lial monolayer within the media layer. For local quantification of 
CD31-positivity, we categorized the media into three equal parts; 
the inner media consisting of the innermost media adjacent to 
the intima, the outer media adjacent to the adventitia, and the 
middle media between these two media layers, respectively. The 
total number of positively stained CD31 new vessels was count-
ed per square millimeter in four arbitrarily selected areas, which 
showed the most increased density of capillary-like morphology 
(hot spots). 
Follow-up protocol
Documentation of mortality and morbidity was available 
for all the patients. For the included study patients, follow-up 
consisted of physical examination and echocardiography at 3 
months after surgery, and on-demand thereafter including CT. 
Statistical analysis
CD31-positive staining was predominantly found in the me-
dia, at the border of the adventitia including formation of small 
vessels (Fig. 1). To seek clinical relevance associated with im-
munohistochemistry, the patients were divided into two groups 
in accordance with the histologically confirmed presence of AD. 
Although histopathology confirms AD, indices of inflammation, 
hemorrhage, or fibrosis do not facilitate the temporal diagnosis 
of AD (11). The patients were categorized in keeping with the 
presence of dissection (AD+) and dilatation only (AD-). All study 
patients were followed for a period of 3 months. Quantitative 
variables are listed as the mean and standard error of the mean. 
Categorical variables are stated as count and percentage. Sta-
tistical analysis was performed with the SPSS version 22.0. The 
Mann-Whitney U test was used for continuous variables, and 
the chi-squared test for categorical analysis. The association of 
CD31 with AD was assessed by the receiver operating charac-
teristic curve (ROC) analysis. P-values less than 0.05 were con-
sidered statistically relevant.
Results
Demographics 
Eighteen patients had ascending AD, while 14 out of 32 pa-
tients were operated for acute AD (Table 1). The mean age was 
Table 1. Patient demographics
 All patients AD+ AD– P-value
Number of patients 32 14 18
Age (years) 64±2 69±2 59±3 0.010
Male, n 22 (69%) 8 (57%) 14 (78%) 0.267
Hypertension, n 13 (41%) 6 (43%) 7 (39%) 1
Diabetes, n 1 (3%) 1 (7%) 0 0.438
Hypercholesterolemia, n 3 (9%) 0 3 (17%) 0.238
Vasculitis, n 1 (3%) 0 1 (6%) 1
Arthritis, n 3 (9%) 3 (22%) 0 0.073
Asthma, n 2 (6%) 1 (7%) 1 (6%) 1
Myocardial coronary artery disease, infarction, n 7 (22%) 3 (22%) 4 (22%) 1
Previous cardiothoracic operation
Coronary artery bypass surgery, n 2 (6%) 2 (15%) 0 0.183
Correction of aortic coarctation, n 1 (3%) 0 1 (6%) 1
Correction of abdominal aorta aneurysm 1 (3%) 1 (7%) 0 0.438
Mid-ascending aorta diameter, mm 58±2 59±3 57±3 0.323
2-cusp aortic valve, n (%) 8 (25%) 1 (7%) 7 (39%) 0.053
Aortic valve insufficiency
Moderate to severe, n 12 (38%) 4 (29%) 8 (45%) 0.471
Aortic valve stenosis
Moderate to severe, n 12 (38%) 1 (7%) 11* (61%) 0.003
*includes five patients with combined aortic valve disease, P=0.001
AD - aortic dissection
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64±2 years. Hypertension and coronary artery disease were 
equally distributed among both groups. One patient without AD 
had unspecified vasculitis of the aortic wall. Four patients with 
AD and eight without AD had aortic valve insufficiency. Eleven 
out of 18 patients without AD had aortic valve stenosis, includ-
ing five patients with combined aortic valve disease, in contrast 
to only one aortic valve stenosis in a patient with AD. The mean 
aortic diameter was 58±2 mm for all patients.
Operative technique 
In patients with AD, surgery included either a Bentall-type 
operation with an aortic valve prosthesis, or replacement of 
the ascending aorta only (Table 2). In eight patients without 
AD, the aortic root was not operated on. A mechanical or 
biologic valve was replaced together with a prosthesis en-
compassing the ascending aorta distally from the sinotubular 
junction in five patients without AD. In three patients without 
AD and without aortic valve disease, only the ascending aorta 
was replaced.
Perioperative findings, histology, and immunohistochemistry
Histology revealed three cases of aortitis, of which two had 
AD+ (Tables 3 and 4). The intensity of chronic adventitial, me-
dial, and intimal inflammation was increased in AD+ as com-
pared with AD− (2.2±0.3 vs. 1.3±0.2, p=0.03, 1.4±0.3 vs. 0.3±0.1, 
p<0.001, and 1.6±0.3 vs. 0.7±0.2, p=0.005, respectively). The me-
dia showed increased cell proliferation in AD+ as compared 
with AD− (1.5±0.3 vs. 0.4±0.2, p=0.002). An increased number 
of macrophages and T-cells of the intima were found in AD+ 
as compared to AD− (1.9±0.2 vs. 1.2±0.2 p=0.032 and 1.4±0.2 
vs. 0.6±0.2, p=0.006, respectively). The outer third layer of the 
media at the vicinity of the adventitia expressed an increased 
number of cytoplasmic CD31-positivity in AD+ as compared 
with AD− (5.1±1.1 vs. 2.4±0.7, p=0.037), and corresponded to 
the site of AD tear (Fig. 1).
Table 2. Operative details according to surgical evaluation of extension of diseased aorta
 All Patients AD+ AD– P-value
 32 14 18
Graft replacement of root and ascending aorta
Mechanical conduit 9 (28%) 3 (22%) 6 (33%) 0.694
Biological conduit 8 (25%) 4 (29%) 4 (22%) 0.703
Graft replacement of ascending aorta
Mechanical valve+prosthesis 2 (7%) 0 2 (11%) 0.492
Biological valve+prosthesis 3 (10%) 0 3* (17%) 0.238
Prosthesis 10 (32%) 7 (50%) 3 (17%) 0.062
Additional procedure
Coronary artery bypass surgery 4 (13%) 2 (15%) 2 (11%) 1
*includes aortoplasty
AD - aortic dissection 
Table 3. Histology and quantitative immunohistochemistry
Mean grade of staining
mm mm All Patients AD+ AD– P-value
Adventitia
 T-cells 1.4±0.2 1.8±0.3 1.1±0.2 0.077
 B-cells 1.0±0.2 1.2±0.4 1.0±0.2 0.791
 Macrophages 1.8±0.2 2.2±0.2 1.5±0.2 0.068
 Plasma cells 0.6±0.2 0.9±0.3 0.6±0.2 0.201
 Inflammation 1.6±0.2 2.2±0.3 1.3±0.2 0.003
 Proliferation 1.5±0.2 1.6±0.2 1.3±0.4 0.561
Media
 T-cells 0.6±0.2 0.8±0.3 0.5±0.2 0.476
 B-cells 0.2±0.1 0.3±0.2 0.1±0.6 0.175
 Macrophages 1.2±0.2 1.5±0.3 1.0±0.3 0.207
 Plasma cells 0.4±0.2 0.3±0.2 0.5±0.4 0.424
 Inflammation 0.8 ± 0.2 1.4±0.3 0.3±0.1 0.001
 Proliferation 0.9±0.2 1.5±0.3 0.4±0.2 0.002
 Degeneration 1.5±0.2 1.7±0.3 1.4±0.3 0.466
 Elastase 1.6±0.2 1.6±0.2 1.6±0.3 0.968
Intima
 T-cells 1.0±0.2 1.4±0.2 0.6±0.2 0.006
 B-cells 0.1±0.1 0.3±0.2 0 0.072
 Macrophages 1.5±0.2 1.9±0.2 1.2±0.2 0.032
 Plasma cells 0.7±0.2 0.7±0.2 0.5±0.4 0.622
 Inflammation 1.1±0.2 1.6±0.3 0.7±0.2 0.005
 Proliferation 0.9±0.2 1.0±0.2 0.5±0.4 0.206
 Thickness 2.0±0.3 1.9±0.3 2.1±0.4 0.706
 Cellularity 1.6±0.2 1.7±0.2 1.3±0.2 0.328
Mean grade of staining expressed as point score units/mm2
AD - aortic dissection 
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ROC analysis and outcome
A ROC analysis showed that the local endothelial activ-
ity was associated with AD (AUC 0.750; SE 0.092; p=0.022; 95% 
CI 0.570–0.930, Fig. 2). Two patients with AD died shortly after 
surgery: a 55-year old preoperatively unconscious patient and 
an 88-year old that experienced AD rupture before the onset 
of hypothermia. Two patients without AD died within 1 week of 
surgery, due to cerebral infarction caused by hypotension and 
cerebral emboli at surgery.
Discussion
Based on this study, local neovascularization of the outer 
medial layer indicates active remodeling of the aortic wall as-
sociated with AD; histological characteristics of the ascending 
aortic wall may be investigated to reveal endothelial activation 
of newly formed capillaries of the media layer according to the 
CD31 positivity. Together with neovascularization, an increased 
number of proliferative cells and macrophages is strongly sug-
gestive of chronic inflammation in patients with AD.
Dilatation of the ascending aorta alone does not undeniably 
lead to AD. Hypertension and a family history for dilatation of 
the aorta may increase the risk for dilatation per se, but AD 
seems to occur in some instances quasi-unexpectedly, while 
the aortic diameter has not reached the threshold value of 5.5 
cm2. According to a large referral center, AD was missed up to 
38% of cases on initial evaluation and first established in 28% 
of patients only at postmortem examination (12). While tradi-
tional CT and echocardiography may not provide an accurate 
estimation of the risk for AD, molecular imaging has emerged 
as a plausible and promising option (13). Risk stratification of 
AD may benefit from understanding the heterogeneous patho-
genesis of the inflammatory process and angiogenesis during 
aortic remodeling. Imaging modalities, such as positron emis-
sion tomography, single photon emission CT, and magnetic 
resonance imaging, with the aid of tracing chronic inflamma-
tion and neovascularization, are intensively studied for clinical 
translation (13).
The clinician craves for an applicable means to diagnose ac-
curately an aorta prone for AD. This study emphasizes the impor-
tance of investigating both chronic inflammation and neovascu-
larization that together may form a trigger for AD. This message 
importantly adds to the clinical transition of imaging modalities 
that are based on tracing chronic inflammation and neovascu-
larization (13). An aortic site characterized by microvessel for-
mation and inflammation during progression of ascending aortic 
dilatation (14) enhances awareness for the need of early surgi-
cal intervention to prevent AD.
The onset of AD includes vertical rupture of the aortic wall 
often at the junction of the media and adventitia (15). This 
aortic wall site suggests that the hypoxic environment of the 
media layer may attract chronic inflammatory components 
and eventually lead to angiogenesis and tissue tear. Endothe-
lial cells form the inner lining of newly formed capillaries and 
render the media–adventitia border susceptible to the onset of 
AD. Inflammation alone without angiogenesis may not suffice 
to initiate AD. There are sparse data on the impact of CD31 im-
munohistochemistry on AD. Dysfunction of the microcirculation 
in the outer media layer of the aorta may suggest ischemia and 
malnutrition of the aortic wall, thus increasing the risk for AD 
(4). The impact of ischemia along with intimal hyperplasia and 
hypertension is not demonstrated in our study among the pa-
tients. It is important to distinguish CD31-stained endothelial 
cells from macrophages, since proinflammatory macrophages 
have experimentally been shown to influence the aortic wall 
during AD (16).
Neovascularization is a key factor to the pathophysiology of 
various arterial diseases, such as atherosclerosis (17), vasculi-
tis (6), intracranial artery aneurysm (18), and abdominal aortic 
aneurysm (5). Neovascularization barely seems to be a conse-
Table 4. Quantitative immunohistochemistry for CD31 
according to location of staining
Mean grade of staining All patients AD+ AD– P-value
Media
 Outer layer 3.5±0.7 5.1±1.1 2.4±0.7 0.037
 Middle layer 1.7±0.3 2.1±0.6 1.4±0.4 0.258
 Inner layer 0.9±0.2 0.7±0.3 1.1±0.4 0.714
Mean grade of staining expressed as point score units/mm2
AD - aortic dissection
Figure 2. Receiver operating characteristic curve analysis shows that 
local neovascularization of the aortic wall is associated with AD (AUC 
0.750; SE 0.092; P=0.022; 95% CI 0.570–0.930)
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quence of hypoxia alone, but it involves mechanisms introduced 
by immunology and subsequent chronic inflammation (5, 6, 19). 
According to a previous experimental model (20), decreased 
circulation of vasa vasorum, which often occurs in arterial hy-
pertension (17), may increase the stiffness of the outer media 
of the aorta, but an immunological activation of the aortic wall 
seems prerequisite to initiate an active tear, which leads to AD 
(17, 19, 21, 22). Chronic inflammation of all aortic layers was 
present in our study, together with neovascularization and AD. 
Comparably, acute plaque rupture of the atherosclerotic coro-
nary artery (23) or the formation of microhemorrhages within 
intracranial artery aneurysms (18) may represent disease enti-
ties initiated by the activation of neovessels (19). It is tempting 
to suggest that CD31 immunohistochemistry may reveal a weak 
aortic wall site prone to AD.
Study limitations
This is a study investigating the association of increased aor-
tic neovascularization in a fairly low number of patients with or 
without AD. Unfortunately, the rate of expansion of the non-re-
paired segments of the aorta was not evaluated to correlate with 
immunohistochemistry, partly due to the small number of patients. 
As a paradigm of comparable tissue preparation in this study, we 
did not systematically investigate aortas obtained from autopsied 
cases. Only less than a third of the patients had bicuspid aortic 
valve disease, and it is beyond our scope to discuss the plausible 
interaction of specific heterogenic aortic valve diseases in the 
development of AD. Increased chronic aortic wall inflammation 
was associated with AD together with neovascularization, but 
specific immunological parameters such as complement activa-
tion remain to be elucidated.
Conclusion
Heterogeneity of the progression of aortic dilatation to AD is 
expected (14). Interacting with chronic inflammation and associ-
ated neovascularization may impact against the development of 
AD. Taken together, we suggest that CD31 immunohistochemistry 
adds to the understanding of the remodeling characteristics of 
the ascending aorta, although further studies are clearly recom-
mended.
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